Cardiovascular diseases (CVDs) are the major causes of morbidity and mortality in persons wit diabetes, and many factors, including hypertension, contribute to this high prevalence of macrovascular complications. (...) Finally, the recent identification of new components of the RAS should provide fertile territory to not only examine new targets linked to the RAS but potentially to design more rational treatments for the prevention of CVD in patients with diabetes and hypertension.
